- Home
- SNBR vs TNXP Comparison
SNBR vs TNXP Comparison
Compare SNBR & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNBR
- TNXP
- Stock Information
- Founded
- SNBR 1987
- TNXP 2007
- Country
- SNBR United States
- TNXP United States
- Employees
- SNBR N/A
- TNXP N/A
- Industry
- SNBR Home Furnishings
- TNXP Biotechnology: Pharmaceutical Preparations
- Sector
- SNBR Consumer Discretionary
- TNXP Health Care
- Exchange
- SNBR Nasdaq
- TNXP Nasdaq
- Market Cap
- SNBR 150.1M
- TNXP 173.9M
- IPO Year
- SNBR 1998
- TNXP N/A
- Fundamental
- Price
- SNBR $5.11
- TNXP $18.76
- Analyst Decision
- SNBR Hold
- TNXP Buy
- Analyst Count
- SNBR 2
- TNXP 1
- Target Price
- SNBR $9.00
- TNXP $70.00
- AVG Volume (30 Days)
- SNBR 550.2K
- TNXP 795.6K
- Earning Date
- SNBR 11-05-2025
- TNXP 11-07-2025
- Dividend Yield
- SNBR N/A
- TNXP N/A
- EPS Growth
- SNBR N/A
- TNXP N/A
- EPS
- SNBR N/A
- TNXP N/A
- Revenue
- SNBR $1,524,620,000.00
- TNXP $9,831,000.00
- Revenue This Year
- SNBR N/A
- TNXP $14.79
- Revenue Next Year
- SNBR $1.02
- TNXP $933.49
- P/E Ratio
- SNBR N/A
- TNXP N/A
- Revenue Growth
- SNBR N/A
- TNXP N/A
- 52 Week Low
- SNBR $4.48
- TNXP $6.76
- 52 Week High
- SNBR $20.73
- TNXP $130.00
- Technical
- Relative Strength Index (RSI)
- SNBR 25.46
- TNXP 34.89
- Support Level
- SNBR $6.07
- TNXP $18.53
- Resistance Level
- SNBR $5.59
- TNXP $20.58
- Average True Range (ATR)
- SNBR 0.47
- TNXP 1.10
- MACD
- SNBR -0.04
- TNXP 0.45
- Stochastic Oscillator
- SNBR 7.02
- TNXP 29.12
About SNBR Sleep Number Corporation
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.